摘要
目的:探讨玻璃酸钠联合氨基葡萄糖治疗膝骨性关节炎(OA)有效性及安全性。方法:将162例膝OA患者随机分成观察组和对照组,对照组84例采用单纯关节内注射透明玻璃酸纳,观察组78例采用关节腔内注射玻璃酸钠联合氨基葡萄糖治疗膝骨性关节炎,比较两组Lysholm膝关节评分。结果:随访12个月后对两组行Lysholm膝关节评分及关节功能评价,两组间比较,差异有统计学意义(P<0.05)。结论:玻璃酸钠联合氨基葡萄糖治疗膝骨性关节炎治疗效果优于单纯关节腔内注射透明玻璃酸钠,有临床应用价值。
Objective： To study the effect and safeness of intra-articular injection of sodium hyaluronate combined glucosamine for knee osteoarthritis （OA）.nethods：162 patients with OA were randomly divided into sodium hyaluronate controled groups（84 cases） and sodium hyaluronate combined glucosamine observative groups（78 cases）,the Lysholm score of the knee joint were evaluated respectively.Results： The Lysholm score of the knee joint showed that there was a significantly different from two groups in the excellent and good rate.Conclusion： Sodium hyaluronate combined glucosamine groups is more effective in treating knee osteoarthritis.
出处
《中国当代医药》
2010年第4期42-43,共2页
China Modern Medicine
